A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients

BLZ-100 (tozuleristide) is an intraoperative fluorescent imaging agent that selectively detects malignant tissue and can be used in real time to guide tumor resection. The purpose of this study was to assess the safety, tolerability, and pharmacokinetics of BLZ-100 and to explore the pharmacodynamic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Miko, Miller, Dennis M., Lowe, Melinda, Rowe, Casey, Wood, Dominic, Soyer, H. Peter, Byrnes-Blake, Kelly, Parrish-Novak, Julia, Ishak, Laura, Olson, James M., Brandt, Gordon, Griffin, Paul, Spelman, Lynda, Prow, Tarl W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355837/
https://www.ncbi.nlm.nih.gov/pubmed/34401600
http://dx.doi.org/10.1016/j.conctc.2021.100830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355837/
https://www.ncbi.nlm.nih.gov/pubmed/34401600
http://dx.doi.org/10.1016/j.conctc.2021.100830

Ejemplares similares